Dtsch Med Wochenschr 2009; 134(42): 2120-2124
DOI: 10.1055/s-0029-1241901
Aktuelle Diagnostik & Therapie | Review article
Nuklearmedizin, Radiologie
© Georg Thieme Verlag KG Stuttgart · New York

Diagnostik bei Fieber unklarer Genese (FUO)

Positronen-Emissions-Tomographie/Computer- tomographie (PET-CT) Diagnosis of fever of unknown origin (FUO) Positron emission tomography/computed tomography (PET-CT)S. Gratz1 , 3 , B. Kemke1 , 2 , W. Kaiser1 , U. Hahn1 , B. Erdtmann1 , M. Schilling1 , B. Schneider1 , T. M. Behr3
  • 1Praxis für Nuklearmedizin und Radiologie, Stuttgart
  • 2Nuklearmedizin, PET-Center Stuttgart, Katharinenhospital, Klinikum Stuttgart
  • 3Klinik für Nuklearmedizin, Philipps-Universität, Marburg
Weitere Informationen

Publikationsverlauf

eingereicht: 10.11.2008

akzeptiert: 29.4.2009

Publikationsdatum:
06. Oktober 2009 (online)

Zusammenfassung

Nuklearmedizinische Entzündungsszintigraphien haben sich bei der septischen Entzündungsherdsuche bewährt. Unbefriedigend bleibt aber bislang die Anwendung nuklearmedizinischer sowie radiologischer, sonographischer Verfahren bei Patienten mit Fieber unklarer Genese (FUO). Im Gegensatz zu akut entzündlichen, septischen Prozessen leiden meist ältere Patienten mit FUO öfters an okkulten Tumoren, atypischen Pneumonien, Hämatoblastosen, malignen Lymphomen etc. Neuerdings erlaubt 18 F(Fluor-18)-Fluordeoxy(i)glukose-PET (18F-FDG PET) treffsicher das Auffinden okkulter Veränderungen und aktuelle Daten zeigen, dass eine diagnostisch wertvolle Einordnung dieser Veränderungen zu verschiedenen Krankheitsentitäten möglich ist.

Summary

Nuclear medicine imaging is now well accepted for the localization of septic foci. But in patients the results of infection scintigraphy, radiology and ultrasound remain unsatisfactory in the diagnosis of fever of unknown origin (FUO). In contrast to septic infections, patients with FUO – mostly in elderly patients – tend to have such conditions as occult tumours, atypical pneumonia, hematoblastosis, malignant lymphomas. 18F(Fluor-18)-Fluordeoxyglucose-PET (18F-FDG PET) has made it possible to localize symptomatically occult changes with a high diagnostic accuracy and to achieve differentiation between benign and malignant changes.

Literatur

  • 1 Baldwin A L, Thurston G. Mechanics of endothelial cell architecture and vascular permeability.  Crit Rev Biomed Eng. 2001;  29 247-278
  • 2 Barghouthi S, Everett K D, Speert D P. Nonopsonic phagocytosis of Pseudomonas aeruginosa requires facilitated transport of D-glucose by macrophages.  J Immunol. 1995;  154 3420-3428
  • 3 Bleeker-Rovers C P, Corstens F H. et al . Fever of unknown origin: prospective comparison of diagnostic value of (18)F-FDG PET and (111)In-granulocyte scintigraphy.  Eur J Nucl Med Mol Imaging. 2004;  31 622-626
  • 4 Bleeker-Rovers C P, Vos F J, Corstens F H, Oyen W J. Imaging of infectious diseases using [18F] fluorodeoxyglucose PET.  Q J Nucl Med Mol Imaging. 2008;  52 17-29
  • 5 Blockmans D, Knockaert D, Maes A. et al . Clinical value of [(18)F]fluoro-deoxyglucose positron emission tomography for patients with fever of unknown origin.  Clin Infect Dis. 2001;  15,32 191-196
  • 6 Brown R S, Wahl R L. Overexpression of Glut-1 glucose transporter in human breast cancer. An immunohistochemical study.  Cancer. 1993;  72 2979-2985
  • 7 Buonomo C, Treves S T. Gallium scanning in children with fever of unknown origin.  Pediatr Radiol. 1993;  23 307-310
  • 8 Buysschaert I, Vanderschueren S, Blockmans D. et al . Contribution of (18)fluoro-deoxyglucose positron emission tomography to the work-up of patients with fever of unknown origin.  Eur J Intern Med. 2004;  15 151-156
  • 9 Chakrabarti R, Jung C Y, Lee T P. et al . Changes in glucose transport and transporter isoforms during the activation of human peripheral blood lymphocytes by phytohemagglutinin.  J Immunol. 1994;  152 2660-2668
  • 10 Chung C J, Hicklin O A, Payan J M, Gordon L. Indium-111-labeled leukocyte scan in detection of synthetic vascular graft infection: the effect of antibiotic treatment.  J Nucl Med. 1991;  32 13-15
  • 11 Davies S G, Garvie N W. The role of indium-labelled leukocyte imaging in pyrexia of unknown origin.  Br J Radiol. 1990;  63 850-854
  • 12 Durack D T, Street A C. Fever of unknown origin--reexamined and redefined.  Curr Clin Top Infect Dis. 1991;  11 35-51
  • 13 Gratz S, Rennen H J, Boerman O C. et al . 99mTc-HMPAO-labeled autologous versus heterologous leukocytes for imaging infection.  J Nucl Med. 2002;  43 918-924
  • 14 Gratz S, Gotthardt M, Pfestroff A. et al . Exogenous cell stimulation for imaging infection.  The Open Medical Imaging Journal. 2008;  2 42-48
  • 15 Gratz S, Behr T M, Herrmann A. et al . Immunoscintigraphy (BW 250/183) in neonates and infants with fever of unknown origin.  Nucl Med Commun. 1998;  19 1037-1045
  • 16 Keidar Z, Gurman-Balbir A, Gaitini D, Israel O. Fever of Unknown Origin: The Role of 18F-FDG PET/CT.  J Nucl Med. 2008;  49 1980-1985
  • 17 Kelly M J, Kalff V, Hicks R J. et al . 111In-oxine labelled leukocyte scintigraphy in the detection and localization of active inflammation and sepsis.  Med J Aust. 1990;  152 352-357
  • 18 Knochel J Q, Koehler P R, Lee T G, Welch D M. Diagnosis of abdominal abscesses with computed tomography, ultrasound, and 111In leukocyte scans.  Radiology. 1980;  137 425-432
  • 19 Knockaert D C, Vanderschueren S, Blockmans D. Fever of unknown origin in adults: 40 years on.  J Intern Med. 2003;  253 263-275
  • 20 Kjaer A, Lebech A M, Eigtved A, Højgaard L. Fever of unknown origin: prospective comparison of diagnostic value of 18F-FDG PET and 111In-granulocyte scintigraphy.  Eur J Nucl Med Mol Imaging. 2004;  31 1342-31343
  • 21 Lorenzen J, Buchert R, Bohuslavizki K H. Value of FDG PET in patients with fever of unknown origin.  Nucl Med Commun. 2001;  22 779-783
  • 22 Majno G, Palade G E. Studies on inflammation. The effect of histamine and serotonin on vascular permeability: an electron microscopic study.  J Biophys Biochem Cytol. 1961;  11 571-605
  • 23 Mamede M, Higashi T, Kitaichi M. et al . [18F]FDG uptake and PCNA, Glut-1, and Hexokinase-II expressions in cancers and inflammatory lesions of the lung.  Neoplasia. 2005;  7 369-379
  • 24 Meller J, Ivancevic V, Conrad M. Clinical value of immunoscintigraphy in patients with fever of unknown origin.  J Nucl Med. 1998;  39 1248-1253
  • 25 Meller J, Altenvoerde G, Munzel U. Fever of unknown origin: prospective comparison of [18F]FDG imaging with a double-head coincidence camera and gallium-67 citrate SPET.  Eur J Nucl Med. 2000;  27 1617-1625
  • 26 Peters A M. Nuclear medicine imaging in fever of unknown origin.  Q J Nucl Med. 1999;  43 61-73
  • 27 Petersdorf R G, Beeson P B. Fever of unexplained origin: report on 100 cases.  Medicine. 1961;  40 1-30
  • 28 Sørensen H T, Mellemkjaer L, Skriver M V. et al . Fever of unknown origin and cancer: a population-based study.  Lancet Oncol. 2005;  6 851-855

Priv.-Doz. Dr. Dr. med. S. Gratz

Praxis für Nuklearmedizin

Seelbergstraße 11

70372 Stuttgart

Telefon: 0711/5538241

Fax: 0711/5538246

eMail: Nuklearmedizin-Gratz@gmx.net

    >